Foresee Pharmaceuticals Current Valuation vs. Shares Owned By Insiders

6576 Stock  TWD 73.70  0.10  0.14%   
Based on Foresee Pharmaceuticals' profitability indicators, Foresee Pharmaceuticals Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Foresee Pharmaceuticals' ability to earn profits and add value for shareholders.
For Foresee Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Foresee Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Foresee Pharmaceuticals Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Foresee Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Foresee Pharmaceuticals Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Foresee Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Foresee Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Foresee Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Foresee Pharmaceuticals Shares Owned By Insiders vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Foresee Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Foresee Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Foresee Pharmaceuticals Co is the top company in current valuation category among its peers. It also is number one stock in shares owned by insiders category among its peers . The ratio of Current Valuation to Shares Owned By Insiders for Foresee Pharmaceuticals Co is about  293,468,132 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Foresee Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Foresee Current Valuation vs. Competition

Foresee Pharmaceuticals Co is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 91.03 Billion. Foresee Pharmaceuticals retains roughly 10.39 Billion in current valuation claiming about 11% of equities under Drug Manufacturers—Specialty & Generic industry.

Foresee Shares Owned By Insiders vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Foresee Pharmaceuticals

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
10.39 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Foresee Pharmaceuticals

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
35.40 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

Foresee Shares Owned By Insiders Comparison

Foresee Pharmaceuticals is currently under evaluation in shares owned by insiders category among its peers.

Foresee Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Foresee Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Foresee Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Foresee Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Foresee Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Foresee Pharmaceuticals Co., Ltd., clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in Taiwan and Europe. Foresee Pharmaceuticals Co., Ltd. was founded in 2013 and is headquartered in Taipei, Taiwan. FORESEE PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.

Foresee Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Foresee Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Foresee Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Foresee Pharmaceuticals' important profitability drivers and their relationship over time.

Use Foresee Pharmaceuticals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Foresee Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foresee Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Foresee Pharmaceuticals Pair Trading

Foresee Pharmaceuticals Co Pair Trading Analysis

The ability to find closely correlated positions to Foresee Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Foresee Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Foresee Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Foresee Pharmaceuticals Co to buy it.
The correlation of Foresee Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Foresee Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Foresee Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Foresee Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Foresee Pharmaceuticals position

In addition to having Foresee Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Materials ETFs Thematic Idea Now

Materials ETFs
Materials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Foresee Stock Analysis

When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.